home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Stopping the Pumps in Chemotherapy-Resistant Tumors

  July, 2 2009 9:05
your information resource in human molecular genetics

A novel type of artificial drug delivery system that blocks cancer cells' ability to expel chemotherapy and thereby acquire drug resistance is published online in Nature Biotechnology. In mice, this approach successfully inhibits the growth of drug-resistant colon, breast and uterine tumors and substantially extends life expectancy.

Himanshu Brahmbhatt and colleagues' technique relies on minicells -- empty, lifeless bacteria without genetic material -- which can be filled with different types of drug. Mice were sequentially given two sets of minicells -- the first filled with small RNA molecules to block production of the pumps that confer drug-resistance, and the second one loaded with toxic chemotherapy drugs to kill the tumor cells with disabled pumps.

Since the drugs are not released into general circulation, they can kill cancer cells at much lower dosage than normally required, thus avoiding undesirable side effects.

Author contacts:

Himanshu Brahmbhatt (EnGeneIC, Sydney, Australia)
E-mail: hbrahmbhatt@engeneic.com

Abstract available online.

(C) Nature Biotechnology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.